During the colonial era, the territory of La Guajira was disputed by the governors of Santa Marta and Venezuela, owing to deposits of pearls.
English pirates, Frenchmen, and Germans also disputed the territory.
Physicians 5 Allied Health Professionals 5 Residents/Fellows 0 Member of the Pediatric Cardiac Intensive Care Society 5 UCSF AHP 0 Family/Caregiver: Sat.
March 11th Family Session S1 Optional Workshop 0 Advanced Pulmonary Hypertension Workshop – BPD: Challenges in Lung and Pulmonary Vascular Growth and Development 3/9/17 / 1PM-5PM S2 Optional Workshop 0 Advanced Nursing in Pediatric Pulmonary Hypertension Workshop 3/9/17 / 10AM-5PM Over the past decade, great strides have been made in our understanding of the pathobiology of pulmonary vascular disease, and from these findings new therapeutic options have emerged.
It occupies most of the Guajira Peninsula in the northeast region of the country, on the Caribbean Sea and bordering Venezuela, at the northernmost tip of South America. Various indigenous tribes populated the arid plains of the region prior to the Spanish arrival to the Americas.
In 1498, Alonso de Ojeda sailed around the peninsula of La Guajira, but the first to set foot in what is known today as La Guajira was the Spanish explorer Juan de la Cosa in 1499.
In 1535, Nicolás de Federmán refound the settlement as the village of Riohacha, as a result of constant attacks.
Contour lines shown for Cerro Campanario only, interval 250 m.
Symbols: D- summit of Cerro Campanario; - selected elevations (in meters); stars- main vent locations for eruptive centers; x- locations of samples in tables 1 and 2; dip symbols show aproximate (primary) attitudes of stacks of lava flows; arrows shows flow directions of arroyos and lavas. View northeastward toward Cerro Campanario from 8 km southwest of the 3,943-m summit. Textures and Sr, Ba, Mg, Fe, K, and Ti compositional profiles in volcanic plagioclase: Clues to the dynamics of calcalkaline magma chambers.
It is increasingly clear that pulmonary vascular pathology is integral to a number of childhood disorders.
In this conference, we will bring together international experts to explore our current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric, and adult pulmonary vascular diseases.